U.S. Ophthalmic Sutures Market Size By Type (Natural, Synthetic), By Material (Nylon, Polyproplene, Silk, PGA), By Coating (Coated, Uncoated), By Material Structure (Monofilament, Multifilament/Braided) By Absorption (Absorbable, Non-absorbable), By Application (Corneal Transplantation Surgery, Cataract Surgery, Vitrectomy, Iridectomy, Oculoplastic Surgery), By End-use (Hospitals, Ambulatory Surgical Centers [ASCs])- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The U.S. ophthalmic sutures market size was exhibited at USD 300.9 million in 2022 and is projected to hit around USD 528.78 million by 2032, growing at a CAGR of 5.8% during the forecast period 2023 to 2032.

Key Pointers:

• U.S. ophthalmic sutures market share from the hospital segment held dominant market share in 2022 and is projected to touch USD 300 million through 2032.
• The industry size from the cataract surgery segment is anticipated to record more than 5.6% CAGR through 2032.
• U.S. ophthalmic sutures market share from the coated segment is expected to grow with more than 5.4% CAGR by 2032.
• U.S. natural ophthalmic sutures market share is expected to reach around USD 170 million through 2032.

Report Scope of the U.S. ophthalmic sutures Market

Growing prevalence of eye diseases in the U.S. is anticipated to expedite the market growth in the coming years. Disorders such as cataract, glaucoma, and detached retina have added to the eye disease burden in the region. As per the National Eye Institute, around 24 million Americans are presently suffering from cataract and an estimated 38.7 million will be affected by the disease by 2030. Usually, surgeries are recommended to treat such severe eye diseases to improve vision. Hence, these diseases are contributing to the demand for ophthalmic suture products that provide optimum outcomes in related surgical procedures.

The postoperative complications related to ophthalmic surgeries may have a negative impact on the industry growth. Lack of proper training and essential expertise can be very risky for the patient undergoing surgery. The possible complications include bleeding, inflammation inside the eye, retinal detachment, infection, etc. According to the American Academy of Ophthalmology, immediate complications related to eye surgeries are allergic reactions to the antibiotic drop, discomfort and swelling of the eyelid, and increased intraocular pressure, among others.

U.S. natural ophthalmic sutures market share is expected to reach around USD 170 million through 2032. These sutures offer adequate strength, can perform self-degradation absorption, and possess non-irritating and carcinogenic characteristics. Moreover, these natural sutures are easy to produce at low cost along with mass production. Natural ophthalmic sutures are considerably recommended in related surgical procedures attributable to good absorption, strong pull, and support wound healing characteristics. Hence, the regional product demand will be influenced by these distinct product traits.

U.S. ophthalmic sutures market share from the coated segment is expected to grow with more than 5.4% CAGR by 2032. Suture coating is known to lessen friction for ease of tissue passage and provides enhanced suture flexibility. This coating material delivers accurate consistent suture tension and holds tensile strength and can also be coated with antibiotics that make them more infection resistant. Coating serves the purpose of modifying the surface that enhances precision and penetration. The current antibiotics used by market players are showing sufficient effectiveness against bacterial resistance. Thus, these coated sutures can be touted as evaluated promising tools in the fight against surgical site infections.

The industry size from the cataract surgery segment is anticipated to record more than 5.6% CAGR through 2032. Growing occurrence of cataract disease is driving the market growth. For instance, in 2021, around 10,000 U.S. cataract surgeons performed around 4 million procedures in the U.S. Some of the key variables driving the market growth are rising accessibility to innovative technologies that boost the quality of cataract surgery coupled with the presence of board-certified skilled surgeons. Moreover, continuous advancements and development in ophthalmic sutures used in these procedures will positively impact the industry expansion.

U.S. ophthalmic sutures market share from the hospital segment held dominant market share in 2022 and is projected to touch USD 300 million through 2032. Increasing number of ophthalmic surgical procedures performed at hospital settings will foster the segmental progression. Moreover, surging number of patients that require critical care along with rising availability of better healthcare infrastructure will propel the market growth. The ease of access to a wide range of surgical treatments, medical evaluation for various ailments, and hygienic conditions in the country are some factors contributing to the industry progression.

Some of the prominent players in the U.S. ophthalmic sutures Market include:

• Medtronic
• Mani
• Corzamedical 
• Teleflex Incorporated
• Ethicon
•  B Braun Melsungen AG
• DemeTECH Corporation  

Segments Covered in the Report

This report forecasts the volume and revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor has segmented the U.S. ophthalmic sutures market.

By Type

• Natural
• Synthetic

By Material

• Nylon
• Polyproplene
• Silk
• PGA
• Others

By Coating

• Coated
• Uncoated

By Material Structure

• Monofilament
• Multifilament/Braided

By Absorption

• Absorbable
• Non-absorbable

By Application

• Cataract Surgery
• Corneal Transplantation Surgery
• Glucoma Surgery
• Vitrectomy
• Oculoplastic surgery
• Others

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Others